Cargando…
Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement
While FDA approved methods of assessment of Estrogen Receptor (ER) are “fit for purpose”, they represent a 30-year-old technology. New quantitative methods, both chromogenic and fluorescent, have been developed and studies have shown that these methods increase the accuracy of assessment of ER. Here...
Autores principales: | Zarrella, Elizabeth, Coulter, Madeline, Welsh, Allison, Carvajal, Daniel, Schalper, Kurt, Harigopal, Malini, Rimm, David, Neumeister, Veronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008858/ https://www.ncbi.nlm.nih.gov/pubmed/27348626 http://dx.doi.org/10.1038/labinvest.2016.73 |
Ejemplares similares
-
Quantitative Measurement of Cancer Tissue Biomarkers in the Lab and in the Clinic
por: Carvajal-Hausdorf, Daniel, et al.
Publicado: (2014) -
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
por: Carvajal-Hausdorf, Daniel E., et al.
Publicado: (2017) -
Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance
por: Carvajal-Hausdorf, Daniel E., et al.
Publicado: (2017) -
Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen
por: Bordeaux, Jennifer M., et al.
Publicado: (2012) -
A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue
por: Neumeister, Veronique M., et al.
Publicado: (2014)